Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Penumbra
PEN
|
+$152M |
| 2 |
CFLT
Confluent
CFLT
|
+$134M |
| 3 |
Rockwell Automation
ROK
|
+$112M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$91M |
| 5 |
Agilent Technologies
A
|
+$57.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutanix
NTNX
|
+$240M |
| 2 |
Zscaler
ZS
|
+$157M |
| 3 |
Northern Trust
NTRS
|
+$142M |
| 4 |
P
Everpure Inc
P
|
+$106M |
| 5 |
Workday
WDAY
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 22.57% |
| 3 | Industrials | 15.37% |
| 4 | Financials | 14.46% |
| 5 | Consumer Staples | 13.23% |
Similar funds
Champlain Investment Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Champlain Investment Partners held 132 positions worth $17.5B, up 3.5% from $16.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Champlain Investment Partners withdrew a net $584M in Q1 2024, closing 6 positions and reducing 71 holdings. Its most notable exit was Northern Trust, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Champlain Investment Partners opened a new position in Confluent worth $145M.
- Champlain Investment Partners's largest Q1 2024 buy was Confluent: 4,736,650 shares worth $145M.
- Champlain Investment Partners added most to Penumbra in Q1 2024, an estimated $152M increase.
- Champlain Investment Partners's biggest Q1 2024 reduction was Nutanix, cutting an estimated $240M.
- Champlain Investment Partners fully exited Northern Trust in Q1 2024, selling an estimated $142M.
- Champlain Investment Partners's ten largest holdings make up 22% of its $17.5B portfolio in Q1 2024.
- Champlain Investment Partners opened 7 new positions and closed 6 in Q1 2024.
- Champlain Investment Partners's portfolio value rose 3.5% quarter-over-quarter to $17.5B.
Based on Champlain Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.